10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0000874716-19-000017`
Period End Date	20190331
Filing Date	20190501
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	idxx-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 36 Cash Flow Statement 58 Stockholders Equity 28 Comprehensive Income 28

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.70M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.57M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$116.62M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$123.79M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Accounts receivable, net of reserves of $4,566 in 2019 and $4,702 in 2018	`AccountsReceivableNetCurrent`	$248.85M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	105.09M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	105.34M	shares	Point-in-time
Accounts receivable, net of reserves of $4,566 in 2019 and $4,702 in 2018	`AccountsReceivableNetCurrent`	$281.16M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	86.10M	shares	Point-in-time
Inventories	`InventoryNet`	$189.47M	USD	Point-in-time
Inventories	`InventoryNet`	$173.30M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	86.05M	shares	Point-in-time
Deferred stock units, outstanding (in shares)	`CommonStockOtherSharesOutstanding`	162,000.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$108.22M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$110.40M	USD	Point-in-time
Deferred stock units, outstanding (in shares)	`CommonStockOtherSharesOutstanding`	162,000.00	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	18.99M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	19.29M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$654.17M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$697.65M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$437.27M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$449.10M	USD	Point-in-time
Operating lease right-of-use assets (Notes 2 and 6)	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Operating lease right-of-use assets (Notes 2 and 6)	`OperatingLeaseRightOfUseAsset`	$80.59M	USD	Point-in-time
Goodwill	`Goodwill`	$214.49M	USD	Point-in-time
Goodwill	`Goodwill`	$214.52M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$39.50M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$41.83M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$189.59M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$199.61M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$883.18M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$983.32M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.68B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.54B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.53M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$70.14M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$229.13M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$260.68M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$398.94M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$347.00M	USD	Point-in-time
Current portion of deferred revenue	`ContractWithCustomerLiabilityCurrent`	$41.29M	USD	Point-in-time
Current portion of deferred revenue	`ContractWithCustomerLiabilityCurrent`	$43.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$689.62M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$770.44M	USD	Point-in-time
Deferred income tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$29.27M	USD	Point-in-time
Deferred income tax liabilities	`DeferredIncomeTaxLiabilitiesNet`	$32.93M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$699.33M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$601.35M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$55.70M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$60.70M	USD	Point-in-time
Long-term operating lease liabilities (Notes 2 and 6)	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term operating lease liabilities (Notes 2 and 6)	`OperatingLeaseLiabilityNoncurrent`	$68.95M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$82.56M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$84.83M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$939.48M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$776.14M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.55B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.63B	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 105,345 shares in 2019 and 105,087 shares in 2018; Outstanding: 86,054 shares in 2019 and 86,100 shares in 2018	`CommonStockValue`	$10.54M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 105,345 shares in 2019 and 105,087 shares in 2018; Outstanding: 86,054 shares in 2019 and 86,100 shares in 2018	`CommonStockValue`	$10.51M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.16B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.14B	USD	Point-in-time
Deferred stock units: Outstanding: 162 units in 2019 and 2018	`CommonStockOtherValueOutstanding`	$4.52M	USD	Point-in-time
Deferred stock units: Outstanding: 162 units in 2019 and 2018	`CommonStockOtherValueOutstanding`	$4.59M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.17B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.27B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-41.79M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-40.02M	USD	Point-in-time
Treasury stock, at cost: 19,290 shares in 2019 and 18,988 shares in 2018	`TreasuryStockValue`	$2.35B	USD	Point-in-time
Treasury stock, at cost: 19,290 shares in 2019 and 18,988 shares in 2018	`TreasuryStockValue`	$2.29B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$-9.51M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$51.56M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$280.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$308.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-48.98M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$51.87M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.54B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.68B	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$537.66M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$576.06M	USD	1 Quarter
Cost of service revenue	`CostOfGoodsAndServicesSold`	$244.46M	USD	1 Quarter
Cost of service revenue	`CostOfGoodsAndServicesSold`	$234.56M	USD	1 Quarter
Gross profit	`GrossProfit`	$331.60M	USD	1 Quarter
Gross profit	`GrossProfit`	$303.10M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$106.58M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$100.10M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$60.36M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$60.93M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$29.02M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$31.51M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$113.04M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$133.14M	USD	1 Quarter
Interest expense	`InterestExpense`	$8.39M	USD	1 Quarter
Interest expense	`InterestExpense`	$9.27M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$40.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$579.00K	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$104.35M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$124.79M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$22.08M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$14.87M	USD	1 Quarter
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$28.00K	USD	1 Quarter
Less: Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$25.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$102.68M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$89.45M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.02	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.19	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.01	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.17	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	87.33M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	86.20M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	88.94M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	87.55M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$21.36M	USD	1 Quarter
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.00M	USD	1 Quarter
Benefit of deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$3.29M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$6.33M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$5.96M	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$628.00K	USD	1 Quarter
Other	`OtherOperatingActivitiesCashFlowStatement`	$1.09M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$33.42M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.80M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$8.07M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$14.52M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$52.30M	USD	1 Quarter
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$49.60M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-1.94M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$699.00K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-1.33M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-3.10M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$34.90M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$34.38M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.73M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$38.21M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	-	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$87.00K	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$284.12M	USD	1 Quarter
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	-	USD	1 Quarter
Net cash (used) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$260.31M	USD	1 Quarter
Net cash (used) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-38.21M	USD	1 Quarter
Repayments on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$-247.50M	USD	1 Quarter
Repayments on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$-52.02M	USD	1 Quarter
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	1 Quarter
Issuance of senior notes	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$100.00M	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$30.00K	USD	1 Quarter
Payment of acquisition-related contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	1 Quarter
Payment of acquisition-related contingent consideration	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$573.00K	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$54.30M	USD	1 Quarter
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$83.49M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$14.55M	USD	1 Quarter
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$11.55M	USD	1 Quarter
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$7.40M	USD	1 Quarter
Shares withheld for statutory tax withholding on restricted stock	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.55M	USD	1 Quarter
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-324.99M	USD	1 Quarter
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.78M	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-569.00K	USD	1 Quarter
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.33M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.18M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.45M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$123.79M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$187.68M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$116.62M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$159.23M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$123.79M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$187.68M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$116.62M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$159.23M	USD	Point-in-time

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Balance beginning of period (in shares)	`CommonStockSharesIssued`	105.09M	shares	Point-in-time
Balance beginning of period (in shares)	`CommonStockSharesIssued`	105.34M	shares	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-48.98M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$51.87M	USD	Point-in-time
Balance beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time
Cumulative effect of accounting changes	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-12.65M	USD	Point-in-time
Beginning balance, adjusted	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1`	$-66.49M	USD	Point-in-time
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Other comprehensive income, net	`OtherComprehensiveIncomeLossNetOfTax`	$1.78M	USD	1 Quarter
Other comprehensive income, net	`OtherComprehensiveIncomeLossNetOfTax`	$2.26M	USD	1 Quarter
Repurchases of common stock, net	`TreasuryStockValueAcquiredCostMethod`	$94.28M	USD	1 Quarter
Repurchases of common stock, net	`TreasuryStockValueAcquiredCostMethod`	$61.13M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$14.09M	USD	1 Quarter
Common stock issued under stock plans	`StockIssuedDuringPeriodValueShareBasedCompensationGross`	$11.42M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.33M	USD	1 Quarter
Share-based compensation cost	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.96M	USD	1 Quarter
Balance end of period (in shares)	`CommonStockSharesIssued`	105.09M	shares	Point-in-time
Balance end of period (in shares)	`CommonStockSharesIssued`	105.34M	shares	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-53.84M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-48.98M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$51.87M	USD	Point-in-time
Balance end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-9.23M	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$102.71M	USD	1 Quarter
Tax expense from unrealized gain on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$40.00K	USD	1 Quarter
Net income	`ProfitLoss`	$89.48M	USD	1 Quarter
Tax expense from unrealized gain on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$128.00K	USD	1 Quarter
Tax expense from unrealized gain (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$-377.00K	USD	1 Quarter
Tax expense from unrealized gain (loss)	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax`	$531.00K	USD	1 Quarter
Tax expense from reclassification adjustment for (gain) loss included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$-249.00K	USD	1 Quarter
Tax expense from reclassification adjustment for (gain) loss included in net income	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax`	$250.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.42M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$5.17M	USD	1 Quarter
Unrealized gain (loss) on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-2.22M	USD	1 Quarter
Unrealized gain (loss) on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$1.48M	USD	1 Quarter
Unrealized gain on investments, net of tax expense of $128 in 2019 and $40 in 2018	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$407.00K	USD	1 Quarter
Unrealized gain on investments, net of tax expense of $128 in 2019 and $40 in 2018	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$118.00K	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $531 in 2019 and $(377) in 2018	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$-2.39M	USD	1 Quarter
Unrealized gain (loss), net of tax expense (benefit) of $531 in 2019 and $(377) in 2018	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax`	$2.47M	USD	1 Quarter
Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $(249) in 2019 and $250 in 2018	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$1.16M	USD	1 Quarter
Reclassification adjustment for (gain) loss included in net income, net of tax (expense) benefit of $(249) in 2019 and $250 in 2018	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax`	$-1.58M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$1.31M	USD	1 Quarter
Unrealized gain (loss) on derivative instruments	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-803.00K	USD	1 Quarter
Other comprehensive gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$1.78M	USD	1 Quarter
Other comprehensive gain, net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$2.26M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$91.74M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$104.48M	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$25.00K	USD	1 Quarter
Less: Comprehensive income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$28.00K	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$91.72M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$104.46M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.